When a United States regulator issued a warning letter to one of the country's largest compounding pharmacies in September, most public attention went to the drug copies and prescriber paperwork. The quieter finding concerned sterile manufacturing discipline: gaps in airflow studies, environmental monitoring and aseptic processing. For PPE buyers, the case is a reminder that hazardous drug handling is audited as a system, and that gloves and footwear sit at the end of that system, where every upstream gap eventually lands on someone's skin.
The List Keeps Moving
The framework starts with identification. The NIOSH list of hazardous drugs in healthcare settings, refreshed most recently in the 2024 edition, added twenty-five drugs and removed seven, and regulators continue to publish individual determinations that move drugs in and out of scope. Around eight million healthcare workers in the United States alone are considered potentially exposed. For a distributor or institutional buyer, the consequence is that a glove programme written three years ago may not cover the molecules a hospital pharmacy handles today, because the hazardous set grows faster than most PPE specifications are reviewed.
Thirty Minutes Is a Floor, Not a Target
USP 800 requires gloves tested to ASTM D6978, the chemotherapy permeation standard, with a minimum breakthrough time of thirty minutes against the drugs a facility uses. Read a typical test panel and the spread is striking: many common agents show breakthrough beyond four hours, while carmustine and thiotepa, small and lipophilic molecules, often struggle to clear the thirty-minute floor at all. Buyers who write D6978-compliant into a tender without naming drugs and breakthrough times are buying the floor, not the performance. Test temperature matters too, because permeation accelerates as a gloved hand warms the film toward skin temperature.
Two Pairs, Changed Often, Doffed Correctly
The handling rules are unforgiving in a different way. Double gloving is required for compounding and most administration tasks, with the inner glove under the gown cuff and the outer glove sealed over it, and gloves are changed every thirty minutes during continuous work or immediately when torn. Sizing must therefore come in matched pairs, with the outer size up. Footwear enters through the spill and waste side: spill kits specify overshoes, compounding rooms require shoe covers, and contaminated waste handling demands the same gown-and-glove sequence. The doffing order in published spill procedures places footwear removal deliberately between the gown and the final glove removal, which makes overshoe design, a wide ankle opening and tear-resistant film, part of the contamination control chain rather than an accessory.
What Buyers Should Put in the Specification
A defensible glove and footwear line for hazardous drug duty names the tested drugs with their breakthrough times and the test temperature, states powder-free construction with an acceptable quality limit for pinholes, defines the double-glove sizing matrix, and requires batch traceability so a facility can document compliance years later. For overshoes and shoe covers, the spec should cover ankle coverage, sole slip resistance on damp floors, and compatibility with the facility's written doffing sequence. None of this is exotic. It is the difference between PPE that passes an audit and PPE that merely looks right on a shelf.